Journal
CURRENT OPINION IN BIOTECHNOLOGY
Volume 52, Issue -, Pages 25-31Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2018.02.009
Keywords
-
Funding
- National Institutes of Health [R21AI119115, R01AI117064, RO1EB2000801A1, RO1EB023776]
Ask authors/readers for more resources
Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but cannot be developed into therapeutics due to challenges in delivering them into the cytoplasm. There is therefore great interest in developing strategies that can enable proteins to enter the cytoplasm of cells. In this review article we will discuss recent progress in intracellular protein therapeutics, which are focused on the following four classes of therapeutics, Firstly, vaccine development, secondly, transcription factor therapies, thirdly, gene editing and finally, cancer therapeutics. These exciting new advances raise the prospect of developing cures for several un-treatable diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available